Ignite Creation Date:
2024-05-05 @ 7:13 PM
Last Modification Date:
2024-10-26 @ 9:45 AM
Study NCT ID:
NCT00625664
Status:
COMPLETED
Last Update Posted:
2016-05-05
First Post:
2008-02-19
Brief Title:
Larotaxel Cisplatin Versus Gemcitabine Cisplatin in First Line Treatment of Locally AdvancedMetastatic Urothelial Tract or Bladder Cancer
Sponsor:
Sanofi
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
EFC6668
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sanofi
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None